Skip to main content

Peptide Therapy in Australia: What to Expect

Peptide Therapy

Peptide therapy in Australia is a prescription-only pathway. A registered practitioner assesses your health history in a real-time consultation, decides whether a plan is suitable for you and sets the review interval. Any prescribed medicine is prepared and dispensed by a licensed Australian pharmacy. Not everyone is suitable, and the risks are discussed before anything starts.

The steps on a regulated peptide therapy pathway

  1. Health questionnaire

    You answer questions about your history, current medicines, symptoms and goals so the practitioner can prepare.

  2. Telehealth consultation

    A registered practitioner assesses you in real time and talks through whether a plan is appropriate.

  3. Pathology, if needed

    The practitioner requests blood tests only where they decide the results are needed.

  4. A decision either way

    The practitioner may set out a plan, suggest something different or decide that nothing should be prescribed.

  5. Pharmacy supply

    Any prescribed medicine is prepared and dispensed by a licensed Australian pharmacy.

  6. Follow-up reviews

    The practitioner decides when you are next reviewed and whether repeat pathology is due.

Not everyone is suitable, and booking a consultation does not mean a prescription will follow.

What Is Peptide Therapy?

Peptides are short chains of amino acids. Your body makes many of them and uses them as signals between cells. Peptide therapy is a loose term for prescription medicines of this type, used under the care of a registered practitioner.

In Australia these medicines are prescription-only. The Therapeutic Goods Administration restricts the advertising of prescription medicines to the public, which is why this page does not name any of them. Your practitioner can name and explain the options that are relevant to you during a consultation.

The evidence is not the same for every medicine in the group. Some have been studied in large human trials for specific conditions. Others have far less human data behind them. Part of a practitioner's job is to weigh that evidence against your history and goals. If you want to understand how that weighing is done, read what evidence-based healthcare means in practice.

What Happens Before Any Plan Is Discussed

A regulated pathway starts with an assessment, not with a product. The order matters, because the practitioner needs to know who you are before deciding whether anything should be prescribed.

A health questionnaire

You answer questions about your health history, current medicines, symptoms and goals. The questionnaire prepares the practitioner for your consultation. It is not a diagnosis and it does not decide the outcome.

A real-time consultation

The Medical Board of Australia expects a real-time telehealth consultation before a doctor prescribes for a patient they have not seen before. A questionnaire on its own does not meet that standard. In the consultation the practitioner confirms your identity, asks about your history and talks through what you are hoping to change.

Bloods, if your practitioner asks for them

Not everyone needs a blood test. Where the practitioner decides pathology is needed, they write the request, you attend a collection centre, and the results go back to them. Pathology is performed and privately billed by a third-party provider. For background on reading a report, see how pathology results are interpreted.

A decision either way

The practitioner may decide a plan is suitable, may suggest something different, or may decide that nothing should be prescribed. Booking a consultation does not mean a prescription will follow.

How the Dose and the Plan Are Decided

A lot of people arrive after reading forum threads where strangers swap doses. This page gives no dosing, because a dose is a clinical decision made for one person.

If a plan is prescribed, your practitioner sets the dose, how often it is taken, how long the plan runs and when it is reviewed. You should leave the consultation able to answer five questions: what has been prescribed and why, how to take it, what to watch for, when the next review is, and what happens if you stop.

If any of those is unclear, ask before you start. Do not change a dose on your own or on advice from a forum. Contact your practitioner instead.

Side Effects and What Is Monitored

Every prescription medicine can cause side effects. For some medicines in this group the long-term human data is limited, and it is reasonable to ask your practitioner directly what is known and what is not.

Before a plan starts, the practitioner should explain the known risks, who should not take the medicine, and which symptoms mean you should stop and get in touch. Follow-up reviews, and repeat pathology where the practitioner decides it is needed, are how a plan is checked over time.

You can report a suspected side effect to your practitioner or pharmacist, and anyone can report one to the Therapeutic Goods Administration. In an emergency, call 000.

Where the Medicine Comes From

On a regulated pathway the medicine is supplied by a licensed Australian pharmacy against an individual prescription. A registered pharmacist is responsible for what is dispensed. Some plans are prepared by a compounding pharmacy, and you can read how compounding pharmacies work in Australia.

Products sold online without a prescription sit outside that system. There is no pharmacist check, and the buyer has no dependable way to confirm what is in the vial. For the wider process from consultation to delivery, see how the Regeniq consultation process works.

What the Process Looks Like With Regeniq

Regeniq facilitates practitioner-led peptide therapy consultations for Australian men, and the steps follow the order above. You start with a short online assessment, with nothing to pay at that stage. You then pay the consultation fee at checkout and choose a time from the practitioner calendar for a private telehealth consultation with an independent AHPRA-registered practitioner. You can read more about the Regeniq peptide therapy pathway.

If treatment is clinically appropriate, your practitioner sets out a care plan with treatment information and the follow-ups they recommend, and you can read it at any time in your patient portal. Where your practitioner prescribes, an Australian partner pharmacy prepares your order and delivers it discreetly to your door. Consultation fees differ by pathway and are listed on the Regeniq pricing page.

Frequently Asked Questions

No prescription medicine is free of risk. How a particular medicine affects you depends on the medicine, the dose, your health history and where it was made. That is why the question belongs in a consultation: a registered practitioner can explain the known risks and the gaps in the evidence for the specific option being considered, and decide whether it is appropriate for you.

Side effects differ from one medicine to another, so a general list would mislead. Ask your practitioner three things before starting: what the common side effects are, which symptoms mean you should stop and make contact, and how the plan will be monitored. Report anything unexpected to your practitioner or pharmacist.

Yes, for the prescription medicines this page covers. In Australia a prescription-only medicine is available only on an individual prescription from a registered practitioner who has assessed you, and it is prepared and dispensed by a licensed Australian pharmacy.

Not necessarily. The consultation is an assessment. The practitioner may decide a plan is suitable, recommend a different approach, or decide that nothing should be prescribed. Not all patients are suitable candidates.

There are usually separate costs: the consultation, the medicine if one is prescribed, delivery, and pathology where the practitioner asks for it. Medicare and private health insurance do not cover these services. Current consultation fees are listed on the pricing page, and every cost is shown before you pay.

Regeniq facilitates consultations with independent AHPRA-registered practitioners. Regeniq does not prescribe, diagnose, compound or dispense. Your practitioner makes the clinical decisions, and a licensed Australian pharmacy dispenses any medicine that is prescribed.

No. Treatment is only considered after a live telehealth consultation, never from a questionnaire alone. The questionnaire helps your practitioner prepare for the consultation and is not a diagnosis.

If treatment is clinically appropriate, your practitioner sets out a care plan with treatment information and the follow-ups they recommend. You can read your care plan at any time in your patient portal.

Your practitioner decides when you are next seen and whether any repeat pathology is due. There is no fixed timetable. You receive a reminder by email and SMS a week before a follow-up or pathology date, and again on the day.

Where Regeniq Fits

Regeniq facilitates telehealth consultations with independent AHPRA-registered practitioners for adults anywhere in Australia. Regeniq does not prescribe, diagnose, compound or dispense. Clinical decisions, including whether any plan is suitable, are made by your practitioner in a real-time consultation. Where a practitioner prescribes, the medicine is prepared and dispensed by a licensed Australian pharmacy.

Related Articles

Want to learn more about evidence-based telehealth?

Our Clinical Approach
A runner on a coastal road, with a warm hillside and the ocean behind.

By joining you agree to receive Regeniq emails. Unsubscribe any time. See our Privacy Policy.